Oxford Nanopore Technologies (LON:ONT) Shares Down 10.2% – What’s Next?

Oxford Nanopore Technologies plc (LON:ONT) was down 10.2% on Monday . The stock traded as low as GBX 127 ($1.60) and last traded at GBX 128.50 ($1.62). Approximately 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average daily volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.80).

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 282 ($3.54) price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 190 ($2.39) price target on shares of Oxford Nanopore Technologies in a research report on Wednesday, September 4th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, Oxford Nanopore Technologies has a consensus rating of “Buy” and a consensus price target of GBX 235.50 ($2.96).

Oxford Nanopore Technologies Trading Down 10.2 %

The company has a market capitalization of £1.21 billion, a P/E ratio of -642.50 and a beta of 0.80. The company has a debt-to-equity ratio of 8.07, a current ratio of 4.45 and a quick ratio of 6.01. The company has a fifty day simple moving average of GBX 142.50 and a two-hundred day simple moving average of GBX 129.63.

Insider Buying and Selling

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,558,158.40). In the last three months, insiders bought 310 shares of company stock valued at $45,010. Company insiders own 32.62% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.